Craig MalzahnSenior Vice President, Technical Operations at REGENXBIO Inc.Speaker
Profile
Craig Malzahn has 25+ years of experience in development, manufacturing, supply chain, and commercialization of gene therapy, monoclonal antibody, and vaccine products. At REGENXBIO, he leads a team of over 90 scientists and engineers, responsible for vector production for research, process development, manufacturing, engineering, and supply chain. Prior to REGENXBIO, Craig was VP and Site Head for GSK’s Rockville large-scale, biopharm commercial manufacturing site. He has also held positions with Human Genome Sciences, Baxter, and North American Vaccines. Craig has a MS in Biotechnology from Johns Hopkins University and a BS in Biology from Virginia Tech.